keyboard_arrow_up

China Avian Influenza Vaccine Industry 2014-2018 Research Report


RnRMarketResearch.com adds report “Research Report on China Avian Influenza Vaccine Industry, 2014-2018” to its store.

Many countries choose to kill all infected poultry to control avian influenza, instead of immunizations. The total number of poultry exceeds 10 billion in China. Epidemic diseases, which are difficult to control, will result in huge losses. Therefore, it is quite necessary to immunize the poultry with avian influenza vaccines.

Avian influenza vaccines have been used for more than 10 years in China. Some poultry farms in China began to use H5N1 avian influenza vaccines voluntarily 10 years ago without compulsory requirements. Chinese avian influenza vaccine industry was in the initial stage in 20012005 with upcoming problems. To resolve these problems, the Ministry of Agriculture of China sets up an entry barrier for the avian influenza vaccine production and imposes strict supervision. The Ministry of Agriculture of China established strict regulations on the production and sales of avian influenza vaccines. For instance, avian influenza vaccines must be produced in workshops that are in compliance with GMP and inspected every year.

In China, the subsidy provided by the government over killing the infected poultry is CNY 10 per bird. In case of serious epidemic diseases, the subsidy amount will be higher.

Complete report available @ http://www.rnrmarketresearch.com/research-report-on-china-avian-influenza-vaccine-industry-2014-2018-market-report.html .

In 2013, the live stock volume of laying hens in China was about 1.4 billion while that of broilers was approximately 10 billion. The output volume of eggs in China was 28.76 million tons in 2013, up by 0.5% YOY. According to National Compulsory Immunization Plan of Animal Epidemic Diseases 2013 issued by Ministry of Agriculture of China, the government conducts compulsory immunizations against 4 diseases, including highly pathogenic avian influenza. The government is responsible for the expenses. In 2013, the market size of avian influenza vaccines exceeded CNY 1 billion in China.

With the increasing living standards of Chinese people, the demand for eggs and poultry meat is growing accordingly, which promotes the development of poultry industry. In China and other neighboring countries, avian influenza, especially highly pathogenic avian influenza, has not been effectively controlled yet. For example, H5N1 highly pathogenic avian influenza broke out in North Korea in May 2013. Besides H5N1, H5 and H7 and other subtype highly pathogenic avian influenza are also highly possible to break out.

Therefore, it is predicted that the market size of avian influenza vaccines will keeping increasing and many animal healthcare enterprises attach attention to this market.

Inquire for discount on this report @ http://www.rnrmarketresearch.com/contacts/discount?rname=212746

Through this report, the readers can acquire the following information:

  • Incidence Status of Avian Influenza
  • Status of Poultry Breeding in China
  • Policy Environment and Government Procurement for Avian Influenza Vaccines in China
  • Supply and demand Status of Avian Influenza Vaccines in China
  • Major Manufacturers of Avian Influenza Vaccines and the Operation Status in China
  • Prospect of China Avian Influenza Vaccine Industry

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Manufacturers and Trading Enterprises of Animal Vaccines
  • Poultry Breeding Enterprises
  • Management Organizations of Livestock Industry
  • Investors and Research Institutes Concerned about the Avian Influenza Vaccine Industry